Tag: Prescription Drugs
Once-Daily TAS-303 Superior to Placebo for Stress Urinary Incontinence
TAS-303 had superior efficacy to placebo at week 12 and was associated with only mild or moderate adverse events
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen Sclerosus
Response rate higher for anogenital versus extragenital lichen sclerosus
Declines Seen in Medical, Nonmedical Use of Prescription Meds Among Teens
Increase seen in prevalence of teens who reported that it would probably be impossible to obtain prescription meds for nonmedical use
Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle Cell
For girls with sickle cell disease, density of growing follicles was marginally lower in hydroxyurea group after adjustment for age
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib
Wearable device data could predict New York Heart Association functional class similarly to clinical measures and six-minute walk test
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A
Authors note high sustained factor VIII activity and protection against bleeding episodes, including bleeding into joints
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
Risankizumab noninferior for clinical remission at week 24, superior for endoscopic remission at week 48
Ofatumumab Effective for MS Across Racial, Ethnic Subgroups
Ofatumumab is more effective than teriflunomide for relapsing multiple sclerosis across subgroups
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
Quarterly out-of-pocket costs increased by approximately $23 on average after age 65 years
